RegulatoryCNBC-TV18
Aurobindo Pharma's Apitoria unit gets 'voluntary action indicated' classification from USFDA
Negative-33
GreyOak summary
Aurobindo Pharma's Apitoria unit received a Voluntary Action Indicated classification from the US FDA following an inspection of its API facility in Andhra Pradesh. The FDA identified three observations requiring voluntary address but closed the inspection without immediate regulatory action.
What it affects
- Aurobindo PharmaAUROPHARMANegative -33
FDA inspection resulted in VAI classification.Rolling sentiment Negative -19
Source
Reported by CNBC-TV18
More Aurobindo Pharma news
- US drug regulator classifies Aurobindo Pharma arm's Andhra facility as 'voluntary action indicated'Economic Times · Regulatory ·
- Geojit raises Aurobindo Pharma target to Rs 2111Moneycontrol · Company update ·